Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis

Exclusion Criteria

• •Signs and symptoms of bacterial conjunctivitis for longer than 4 days prior to Day 1;
• •Presence of concomitant viral infection;
• •Infants with ophthalmia neonatorum of gonococcal, Chlamydia, herpetic or chemical origin;
• •Infants whose birth mothers had any sexually transmitted disease within 1 month prior to delivery;
• •Infants undergoing treatment for retinopathy of prematurity;
• •Contact lens wear during the course of the study;
• •Only 1 sighted eye or vision in either eye not correctable to 0.6 logMAR units (20/80) or better;
• •Use of medications, as specified in the protocol;
• •Any systemic or ocular disease or disorder, complicating factors or structural abnormality that could negatively affect the conduct or outcome of the study;
• •Known or suspected allergy or hypersensitivity to fluoroquinolones;
• •Pregnant, lactating, or of childbearing potential and not using adequate birth control to prevent pregnancy;